Search
for
Sort by
Research 661–690 of 1000+
- Androgens in women
- Vaniqa--eflornithine 13.9% cream.
- Evaluation of platelet-rich plasma as a treatment for androgenetic alopecia: A randomized controlled trial
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- A Missense Mutation in the Cadherin Interaction Site of The Desmoglein 4 Gene Underlies Localized Autosomal Recessive Hypotrichosis
- Standardizing the Classification and Description of Follicular Unit Transplantation and Mini-Micrografting Techniques
- Diagnosis and Management of Primary Cicatricial Alopecia: Part II
- Treatments for unwanted facial hair.
- Evaluation of Hair Density in Different Ethnicities in a Healthy American Population Using Quantitative Trichoscopic Analysis
- European Consensus on the evaluation of women presenting with excessive hair growth
- ANDROGENETIC ALOPECIA
- Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin
- Somatostatin Expression in Human Hair Follicles and Its Potential Role in Immune Privilege
- Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients
- Towards a consensus on how to diagnose and quantify female pattern hair loss – The ‘Female Pattern Hair Loss Severity Index (FPHL-SI)’
- Hair Transplantation Update
- Safety of Topical Minoxidil Solution: A One-Year, Prospective, Observational Study
- Rapp-Hodgkin syndrome: A review of the aspects of hair and hair color
- The Infatuation With Biotin Supplementation: Is There Truth Behind Its Rising Popularity? A Comparative Analysis of Clinical Efficacy versus Social Popularity.
- Assessment of hair density and caliber in Caucasian and Asian female subjects with female pattern hair loss by using the Folliscope
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Wigs and hairpieces: Evaluating dermatologic issues
- Management of Androgenetic Alopecia
- Alopecia: unapproved treatments or indications
- The Alopecia Areata Severity and Morbidity Index (ASAMI) Study
- Secondary cicatricial and other permanent alopecias
- Practical management of hair loss.
- Alopecia Areata is Associated with Increased Expression of Heart Disease Biomarker Cardiac Troponin I
- Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience